Method for establishing early screening scale for risk assessment of gestational diabetes
A technology for gestational diabetes and risk assessment, which is applied in biochemical equipment and methods, microbiological measurement/inspection, health index calculation, etc., can solve the problems of high false negative rate and inconsistency of genes, and achieve good accuracy, Improved perinatal outcome, good correlation
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0026] Through the review of authoritative scientific research literature at home and abroad, first determine the selection criteria for the susceptibility gene SNP:
[0027] 1. If there is a case-control analysis of GWAS in Chinese cohort studies, and there are significant differences, the impact of sample size on data value should also be considered;
[0028] 2. There is a case-control analysis of GWAS in Europeans, and there are significant differences, and it has been verified in a Chinese cohort study;
[0029] 3. The case-control analysis of the candidate gene method in the multi-center study of Chinese people, there is a significant difference, and the results are consistent;
[0030] 4. The results of gene functional studies in the Chinese population are consistent, and it is related to the occurrence of gestational diabetes.
[0031] Through the above four criteria, a total of 28 candidate gene loci were found as shown in Table 1:
[0032] Table 1 Candidate gene loc...
Embodiment 2
[0036] Design primers for nucleic acid mass spectrometry analysis of each SNP site, perform PCR amplification and gene detection;
[0037] The primer design for nucleic acid mass spectrometry analysis of each SNP site is shown in Table 2:
[0038] Table 2 Primers for nucleic acid mass spectrometry analysis of each SNP site
[0039]
[0040]
[0041]
[0042] To save detection costs, set the reaction system to 5 μL:
[0043] Reaction system for PCR amplification (5μL)
[0044] reaction system:
[0045] Template DNA 1 μL,
[0046] Primer mix 1μL,
[0047] 10×Buffer 0.5μL,
[0048] MgCl2 (25mM) 0.4μL,
[0049] dNTP (25mM) 0.1 μL,
[0050] Hotstar (5U / μL),
[0051] ddH2O 1.8 μL;
[0052] Reaction conditions: Place the sealed 384-well plate on an ABI9700 PCR instrument for reaction: pre-denaturation at 95°C for 2min, (95°C for 30s, 56°C for 30s, 72°C for 1min) for 45 cycles, 72°C for 5min, Hold 4°C.
Embodiment 3
[0054] To establish a risk assessment model for complex diseases, first establish the role of each gene locus in the occurrence of the disease through the case-control analysis data in the literature that meets the requirements (need to meet: original data, high article quality rating, Chinese cohort data). Weights, expressed as OR values.
[0055] Each locus has 3 genotypes aa, ab and bb. The OR values of the three genotypes are ORa, ORab, ORb, respectively. The genotype frequencies of each genotype in Asians are Pa, Pab, Pb, respectively. Then the genetic risk value of the disease can be calculated by the following formula:
[0056] RI=(Pa1*ORa1+Pb1*ORb1+Pab1*ORab1)*(Pa2*ORa2+Pb2*ORb2+Pab2*ORab2)*...*(Pa28*ORa28+Pb28*ORb28+Pab1*ORab28)
[0057] The individual's genetic risk value is PI=OR1*OR2*...*OR28 / RI.
[0058] The PI value is compared with the prevalence rate of the population, the lifetime risk of the subject is the multiple of the population level. If it exceed...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com